Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake?The Motley Fool • 03/13/26
Bio-Techne Corporation (TECH) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha • 03/10/26
Bio-Techne Corporation (TECH) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha • 03/03/26
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical LaboratoriesPRNewsWire • 02/16/26
Techne (TECH) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/04/26
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic AlternativePRNewsWire • 02/02/26
Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological BiomarkersPRNewsWire • 01/28/26
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial ResultsPRNewsWire • 01/20/26
Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein AnalysisPRNewsWire • 12/09/25
Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference TranscriptSeeking Alpha • 12/09/25
Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 TranscriptSeeking Alpha • 12/03/25